Home / Going-concern warnings / Humacyte, Inc.
Filed 2026-08-12 路 Form 10-Q 路 Accession 0001193125-26-347022 micro
Price before filing: $0.71 (2026-08-11 close, split/dividend-adjusted)
Market cap at flag: $155.7M (2026-08-12) 路 Latest: $100.5M (2026-10-16)
| Window | HUMA | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -20.1% | -0.8% | -19.2% | 2026-09-11 |
| 90 days | pending | pending | until 2026-11-10 | |
| 180 days | pending | pending | until 2027-02-08 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 2 insiders sold $82K (2 sales); 2 insiders bought $60K (2 purchases)
30 days after: 1 insider bought $25K (2 purchases)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Constantino Michael T. Director | Purchase | 11,000 | $0.89 | $10K | no | Form 4 |
| 2026-05-18 | Parikh Shamik J Chief Medical Officer | Sale | 45,887 | $0.90 | $41K | yes | Form 4 |
| 2026-05-18 | Sander Dale A. CFO and Chief Corp. Dev. Off | Sale | 45,887 | $0.90 | $41K | yes | Form 4 |
| 2026-05-19 | Sebelius Kathleen Director | Purchase | 56,818 | $0.88 | $50K | no | Form 4 |
| 2026-08-12: red flag filed | |||||||
| 2026-08-17 | Jones Keith Anthony Director | Purchase | 30,000 | $0.59 | $18K | no | Form 4 |
| 2026-08-20 | Jones Keith Anthony Director | Purchase | 10,000 | $0.69 | $7K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-05-14 to 2026-09-11. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"These factors raise substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2026-06-30)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.